Zobrazeno 1 - 10
of 275
pro vyhledávání: '"Emmanuel, Oger"'
Autor:
Marion Rolland, Emmanuel Oger, Monica Dinulescu, Thierry Lesimple, David Russo, Marc Pracht, Marc Porneuf, Sophie Dalac, Damien Giacchero, Thomas Jouary, Celeste Lebbé, Marie-Thérèse Leccia, Eve Maubec, Nicolas Meyer, Laurent Mortier, Alain Dupuy
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 4, Pp 708-717 (2023)
Abstract Background In 2018, the European Medicines Agency authorized adjuvant therapy for patients with resected stage III melanoma. Objectives The objective of the present study (performed in France) was to assess dermatologists' and oncologists' o
Externí odkaz:
https://doaj.org/article/f486343e3ac74e1db66a25d920f345c4
Autor:
Elizabeth Curtis, Erwan Donal, Charlotte Lee, Emmanuel Oger, Corentin Bourg, Erwan Le Tallec, Guillaume Bouzille, Alain Lescort
Publikováno v:
Open Heart, Vol 11, Iss 1 (2024)
Background Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease. Cardiac involvement in SLE is rare but plays an important prognostic role. The degree of cardiac involvement according to SLE subsets defined by non-cardiac manifest
Externí odkaz:
https://doaj.org/article/8d5101dd0fed4255a267d5108fc2a267
Autor:
Angiza Shahim, Marion Hourqueig, Lars H. Lund, Gianluigi Savarese, Emmanuel Oger, Ashwin Venkateshvaran, Lina Benson, Jean‐Claude Daubert, Cecilia Linde, Erwan Donal, Camilla Hage
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 1835-1846 (2023)
Abstract Aims Heart failure (HF) with preserved ejection fraction (HFpEF) is associated with cardiovascular (CV) and non‐CV events, but long‐term risk is poorly studied. We assessed incidence and predictors of the long‐term CV and non‐CV even
Externí odkaz:
https://doaj.org/article/342ff86e829f4860b001050684b19185
Autor:
Guillaume L'Official, Mathilde Vely, Wojciech Kosmala, Elena Galli, Anne Guerin, Elisabeth Chen, Catherine Sportouch, Julien Dreyfus, Emmanuel Oger, Erwan Donal
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 1605-1614 (2023)
Abstract Aims Functional tricuspid regurgitation (TR) is a turning point in cardiac diseases. Symptoms typically appear late. The optimal timing for proposing a valve repair remains a challenge. We sought to analyse the characteristics of right heart
Externí odkaz:
https://doaj.org/article/8451023cd7494ca7af28894e84c3145a
Autor:
Emmanuel Oger, Sandrine Kerbrat, Emmanuel Nowak, François Paillard, Pierre‐Yves Scarabin, André Happe
Publikováno v:
The Journal of Clinical Hypertension, Vol 24, Iss 4, Pp 438-448 (2022)
Abstract Angiotensin‐converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) both inhibit the renin‐angiotensin system (RAS) but have different sites of action. Whether clinically meaningful differences exist is still debat
Externí odkaz:
https://doaj.org/article/c0909cf7b3c84d62af060bc41614e1ba
Autor:
Lars H. Lund, Gianluigi Savarese, Ashwin Venkateshvaran, Lina Benson, Anna Lundberg, Erwan Donal, Jean‐Claude Daubert, Emmanuel Oger, Cecilia Linde, Camilla Hage
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 164-177 (2022)
Abstract Aims In the heart failure (HF) with preserved ejection fraction (HFpEF) PARAGON‐HF trial, sacubitril/valsartan vs. valsartan improved mortality/morbidity in patients with left ventricular ejection fraction (LVEF) below median (57%). We ass
Externí odkaz:
https://doaj.org/article/9e027f820e8349e3b7a6afd9ee7b6cb0
Autor:
Angiza Shahim, Marion Hourqueig, Erwan Donal, Emmanuel Oger, Ashwin Venkateshvaran, Jean‐Claude Daubert, Gianluigi Savarese, Cecilia Linde, Lars H. Lund, Camilla Hage
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 4243-4254 (2021)
Abstract Aims Heart failure (HF) with preserved ejection fraction (HFpEF) has poor long‐term prognosis. We assessed rates and predictors of outcome 10 years after an acute episode of HF. Methods and results The Karolinska‐Rennes (KaRen) study enr
Externí odkaz:
https://doaj.org/article/120946da82434f93859b58e839a23141
Autor:
Alain Lescoat, Guillaume Coiffier, Catherine Droitcourt, Emmanuel Oger, Alain Dupuy, Pauline Berthe, Lucie-Marie Scailteux, Delphine Staumont, Pierre Guéret
Publikováno v:
BMJ Open, Vol 12, Iss 9 (2022)
Introduction Atopic dermatitis (AD) is a highly prevalent, chronic, inflammatory skin disease. Several orally administered Janus kinase inhibitors (JAKis, including baricitinib, upadacitinib and abrocitinib) have received a marketing authorisation fo
Externí odkaz:
https://doaj.org/article/3795381be54b47dba028e6b5b7c27b02
Publikováno v:
BMC Medical Research Methodology, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background Validation studies on an ICD-10-based algorithm to identify major bleeding events are scarce, and mostly focused on positive predictive values. Objective To evaluate the sensitivity and specificity of an ICD-10-based algorithm in
Externí odkaz:
https://doaj.org/article/04461ff915cd41449687533e18cc504b
Autor:
Catherine Droitcourt, Sébastien Barbarot, Annabel Maruani, Laure Darrieux, Laurent Misery, Emilie Brenaut, Henri Adamski, Cécile Chabbert, Annie Vermersch, Marie Weiborn, Julien Seneschal, Alain Taïeb, Patrice Plantin, Hervé Maillard, Alice Phan, François Skowron, Manuelle Viguier, Delphine Staumont-Salle, Audrey Nosbaum, Angèle Soria, Annick Barbaud, Emmanuel Oger, Alain Dupuy, Groupe de Recherche sur l’Eczéma Atopique de la Société Française de Dermatologie (GREAT)
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Background Atopic dermatitis is a highly prevalent, chronic, relapsing disease in both adults and children. On the severity spectrum, lower-end patients benefit from small amounts of topical anti-inflammatory treatments (TAT), whereas higher
Externí odkaz:
https://doaj.org/article/48163d29d5eb45428527d785addcb5b6